NOTE: To place order using Credit Card, P-Card, or Purchase Order – please choose kit size above and click “Add to cart” button. You can place order online without creating an account.
Transfection Reagent for J774A Cells (Melanoma Cells, TIB-67)
Two component formulation enhances lipid mediated transfection efficiency
Optimized easy-to-use transfection protocol provided for transfection of siRNA, DNA, mRNA, and microRNA
Kit includes Transfection Enhancer reagent and recommended transfection protocol
High transfection efficacy in the presence of serum
Expand your RNAi application with a reagent optimized for delivery of both siRNA and plasmid
Reproducible transfection results
Works well for standard reverse transfection and high-throughput applications
- Download PowerPoint presentation for J774A cells transfection kit: [PPT]
Developed and manufactured by Altogen Biosystems
Reagent exhibits at least 87% transfection efficiency of siRNA delivery. Transfection efficiency was determined by qRT-PCR.
Transfection Protocol and MSDS:
Download Altogen Biosystems J774A Transfection Protocol: [PDF]
Download MSDS: [PDF]
J774A Cell Line:
The J774A.1 cell line was established using ascites tissue taken from an adult female mouse (Mus musculus) which suffered from reticulum cell sarcoma. These macrophage like cells can be used as a transfection host in DNA transfection, and in testing biological response. J774A.1 has been known to synthesize significant amounts of lysozyme. These cells double every 17 hours. They express receptors complement (c3), Fc receptor, IgG, and high affinity I.
Figure 1. Cyclophilin B silencing efficiency was determined by qRT-PCR in the J774A cells transfected by Cyclophilin B siRNA or non-silencing siRNA control following the recommended transfection protocol. Cyclophilin mRNA expression levels were measured 48 hours post-transfection. 18S rRNA levels were used to normalize the Cyclophilin B data. Values are normalized to untreated sample. Data are presented as means ± SD (n=6).
Figure 2. Protein expression of Cyclophilin B in J774A cells. DNA plasmid expressing Cyclophilin B or siRNA targeting Cyclophilin B were transfected into J774A cells following Altogen Biosystems transfection protocol. At 72 hours post-transfection the cells were analyzed by Western Blot for protein expression levels (normalized by total protein, 10 µg of total protein loaded per each well). Untreated cells used as a negative control.
Altogen Biosystems is a life sciences company that offers cell type-specific and pre-optimized transfection products, electroporation kits, and in vivo delivery reagents. Advanced formulation of reagents and optimized transfection protocols provide efficient intracellular delivery of protein, DNA, mRNA, shRNA and siRNA molecules. Read more about transfection technology at Altogen’s Transfection Resource.
Altogen Research Services:
Altogen Labs provides GLP-compliant contract research studies for pre-clinical research, IND applications, and drug development. Biology CRO services include: Xenograft models (30+), development of stable cell lines, ELISA assay development, cell-based and tissue targeted RNAi studies, safety pharm/tox assays, and other studies (visit AltogenLabs.com).
- 0.5 ml (Catalog #6835)
- 1.5 ml (Catalog #6836)
- 1.5 ml CRISPR (Catalog #2162)
- 8.0 ml (Catalog #7051)